Welcome to our dedicated page for HAWKINS SEC filings (Ticker: HWKN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on HAWKINS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into HAWKINS's regulatory disclosures and financial reporting.
Hawkins, Inc. is calling a fully virtual annual shareholder meeting on July 29, 2026. Shareholders of record as of June 5, 2026, holding 20,906,400 common shares, may vote online, by phone, mail, or during the live webcast.
Investors are asked to elect eight directors, ratify Deloitte & Touche LLP as auditor for the year ending March 28, 2027, and approve a non-binding “say‑on‑pay” vote on executive compensation. The board recommends voting FOR all three proposals.
The proxy details an independent board majority, active audit, compensation, and governance committees, and a performance‑based pay program. For fiscal 2026, CEO Patrick H. Hawkins received total compensation of $3.6 million, heavily weighted to performance‑linked stock and incentives tied to income before income taxes and segment profitability.
HAWKINS INC officer Dan Louismet, who serves as VP, General Counsel and Secretary, has filed a Form 3 showing his beneficial ownership in the company. The filing reports direct ownership of 6.0050 shares of Hawkins common stock, providing a baseline view of his insider equity position.
Hawkins, Inc. filed a report describing a leadership classification change. On May 13, 2026, Vice President – Stauber Shirley A. Rozeboom was determined to no longer be an executive officer of the company, effective the same day.
The change is described as part of a planned transition related to a realignment of reporting segments that first took effect for the fiscal year ended March 29, 2026. Ms. Rozeboom continues to be employed by Hawkins, Inc.
HAWKINS INC vice president of Health and Nutrition, Shirley A. Rozeboom, reported routine equity compensation activity. She received a grant of 1,906 shares of Common Stock on May 13, 2026, bringing her direct holdings to 34,087.8625 shares. Earlier, on March 30, 2026, 3,608 shares were withheld at $151.62 per share to satisfy tax obligations, a non‑market disposition. Her holdings also reflect additional shares acquired through the issuer’s dividend reinvestment and employee stock purchase plans.
Hawkins Inc. vice president Douglas A. Lange reported a stock award of 1,994 shares of common stock, received as a grant with no cash paid per share. After this compensation-related acquisition, his direct holdings total 27,146.711 shares. He also reports indirect holdings of 941.214 shares through an IRA and 756.2655 shares through an ESOP trustee.
HAWKINS INC Executive VP and CFO Jeffrey P. Oldenkamp reported an equity compensation grant of common stock. He received 8,435 shares of Hawkins common stock as a grant, award, or other acquisition at a reported price of $0.00 per share, increasing his directly held stake to 102,818.4839 shares. A separate entry shows 1,495.9607 shares of common stock held indirectly "by ESOP Trustee," reflecting his interest in the company’s employee stock ownership plan.
HAWKINS INC vice president of operations Drew M. Grahek reported a stock award of 2,697 shares of common stock at no cost. After this grant, he directly holds 37,135.5051 shares. He also has 905.4307 shares held indirectly through an ESOP trustee. The direct total includes shares acquired under the employee stock purchase plan and the dividend reinvestment plan.
Mangine David J. reported acquisition or exercise transactions in this Form 4 filing.
Hawkins Inc. executive David J. Mangine reported an equity grant of common stock. On May 13, 2026, he received 1,906 shares of Hawkins common stock as a grant or award at $0.00 per share, increasing his direct holdings to 27,763.2393 shares.
In addition to these directly held shares, Mangine is also reported as having indirect ownership of 29.729 shares through a trust and 9,780.201 shares through an ESOP trustee. The filing shows no open‑market purchases or sales, indicating this is a compensation-related award rather than a discretionary trade.
HAWKINS INC executive Gregory Alan Jones, VP of Food and Health Sciences, acquired 1,970 shares of common stock as a stock grant on May 13, 2026. The award was recorded at $0.00 per share, reflecting compensation rather than a market purchase.
After this grant, Jones directly holds 10,144.4943 common shares. This total includes 0.4943 shares accumulated through the company’s dividend reinvestment plan between August 2025 and February 2026, and 194 shares acquired via the employee stock purchase plan between June and December 2025.